Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Analyst Rating of “Hold”

Editas Medicine logo

Editas Medicine, Inc. (NASDAQ:EDIT – Get Rating) received an average rating of “Hold” from the ten rating companies that cover the stock, reports MarketBeat Ratings. Three analysts rated the stock with a sell rating, four assigned a hold rating and one issued a buy rating on the company. The average 1-year target price among brokers … Read more